Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 15401 - 15425 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Bortezomib	Approved Investigational	POLM	27434	downregulated	Bortezomib results in decreased expression of POLM mRNA	7p13	A21434
Bortezomib	Approved Investigational	POLR3E	55718	upregulated	Bortezomib results in increased expression of POLR3E mRNA	16p12.2	A21434
Bortezomib	Approved Investigational	POLR3H	171568	downregulated	Bortezomib results in decreased expression of POLR3H mRNA	22q13.2	A21434
Bortezomib	Approved Investigational	PPM1A	5494	upregulated	Bortezomib results in increased expression of PPM1A mRNA	14q23.1	A21434
Bortezomib	Approved Investigational	PPM1F	9647	upregulated	Bortezomib results in increased expression of PPM1F mRNA	22q11.22	A21434
Bortezomib	Approved Investigational	PPP1R15A	23645	upregulated	Bortezomib results in increased expression of PPP1R15A mRNA	19q13.2	A21440 A21441
Bortezomib	Approved Investigational	PPP2R2A	5520	upregulated	Bortezomib results in increased expression of PPP2R2A mRNA	8p21.2	A21434
Bortezomib	Approved Investigational	PPP2R5D	5528	downregulated	Bortezomib results in decreased expression of PPP2R5D mRNA	6p21.1	A21434
Bortezomib	Approved Investigational	PPP3R1	5534	downregulated	Bortezomib results in decreased expression of PPP3R1 mRNA	2p14	A21434
Bortezomib	Approved Investigational	PPP5C	5536	downregulated	Bortezomib results in decreased expression of PPP5C mRNA	19q13.32	A21434
Bortezomib	Approved Investigational	PRDM2	7799	downregulated	Bortezomib results in decreased expression of PRDM2 mRNA	1p36.21	A21434
Bortezomib	Approved Investigational	PRF1	5551	downregulated	Bortezomib results in decreased expression of PRF1 mRNA	10q22.1	A21434
Bortezomib	Approved Investigational	PRKDC	5591	downregulated	Bortezomib results in decreased expression of PRKDC mRNA	8q11.21	A21434
Bortezomib	Approved Investigational	PRNP	5621	upregulated	Bortezomib results in increased expression of PRNP mRNA	20p13	A21434
Bortezomib	Approved Investigational	PRPF6	24148	downregulated	Bortezomib results in decreased expression of PRPF6 mRNA	20q13.33	A21434
Bortezomib	Approved Investigational	PRR7	80758	downregulated	Bortezomib results in decreased expression of PRR7 mRNA	5q35.3	A21434
Bortezomib	Approved Investigational	PRSS2	5645	downregulated	Bortezomib results in decreased expression of PRSS2 mRNA	7q34	A21434
Bortezomib	Approved Investigational	PSAP	5660	upregulated	Bortezomib results in increased expression of PSAP mRNA	10q22.1	A21434
Bortezomib	Approved Investigational	PSEN1	5663	downregulated	Bortezomib results in decreased expression of PSEN1 mRNA	14q24.2	A21434
Bortezomib	Approved Investigational	PSMC4	5704	upregulated	Bortezomib results in increased expression of PSMC4 mRNA	19q13.11-q13.13	A21434
Bortezomib	Approved Investigational	PSMD12	5718	upregulated	Bortezomib results in increased expression of PSMD12 mRNA	17q24.2	A21434
Bortezomib	Approved Investigational	PSMD13	5719	upregulated	Bortezomib results in increased expression of PSMD13 mRNA	11p15.5	A21434
Bortezomib	Approved Investigational	PSMD7	5713	upregulated	Bortezomib results in increased expression of PSMD7 mRNA	16q23.1	A21434
Bortezomib	Approved Investigational	PSMF1	9491	downregulated	Bortezomib results in decreased expression of PSMF1 mRNA	20p13	A21434
Bortezomib	Approved Investigational	PTBP1	5725	downregulated	Bortezomib results in decreased expression of PTBP1 mRNA	19p13.3	A21434

Displaying entries 15401 - 15425 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability